← Evidence map

ReviewCancer metastasis reviews2022

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions.

Carrie S Wynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35142964